Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons
- PMID: 1677419
Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons
Abstract
Infection with the human immunodeficiency virus (HIV) results in progressive depletion of the CD4 subset T-lymphocytes and the development of opportunistic infections and certain malignancies. Charts were reviewed for 185 HIV-infected individuals with 265 AIDS-defining illnesses (ADIs) who had T-lymphocyte subset analyses performed within 2 months prior to or 1 month following the diagnosis. Also included were 22 HIV-infected patients with oral candidiasis and 20 with asymptomatic infection. Significant differences in CD4 lymphocyte numbers were observed between the 12 ADIs, oral candidiasis, and asymptomatic infection, allowing them to be grouped into five general categories, based on mean CD4 count: (a) asymptomatic infection, CD4 greater than 500/mm3; (b) oral candidiasis and tuberculosis, range 250-500/mm3; (c) Kaposi's sarcoma, lymphoma, and cryptosporidiosis, range 150-200/mm3; (d) Pneumocystis carinii pneumonitis, disseminated Mycobacterium avium complex, herpes simplex ulceration, toxoplasmosis, cryptococcosis, and esophageal candidiasis, range 75-125/mm3; (e) cytomegalovirus retinitis, less than 50/mm3. Our data concur with clinical impressions and provide a basis for interim treatment and prophylaxis recommendations.
Similar articles
-
[CD4+ lymphocytes and opportunistic infections and neoplasms in patients with human immunodeficiency virus infection].Med Clin (Barc). 1994 Apr 23;102(15):566-70. Med Clin (Barc). 1994. PMID: 7646597 Spanish.
-
The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.J Infect. 2001 Feb;42(2):134-9. doi: 10.1053/jinf.2001.0810. J Infect. 2001. PMID: 11531320
-
Natural history of opportunistic disease in an HIV-infected urban clinical cohort.Ann Intern Med. 1996 Apr 1;124(7):633-42. doi: 10.7326/0003-4819-124-7-199604010-00003. Ann Intern Med. 1996. PMID: 8607591
-
HIV infection and AIDS.P N G Med J. 1996 Sep;39(3):174-80. P N G Med J. 1996. PMID: 9795558 Review.
-
Prophylaxis for Pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus.Clin Infect Dis. 1992 May;14(5):1005-9. doi: 10.1093/clinids/14.5.1005. Clin Infect Dis. 1992. PMID: 1350925 Review.
Cited by
-
Outcomes following cholecystectomy in human immunodeficiency virus-positive patients treated with antiretroviral therapy: A retrospective cohort study.Glob Health Med. 2022 Dec 31;4(6):309-314. doi: 10.35772/ghm.2022.01051. Glob Health Med. 2022. PMID: 36589218 Free PMC article.
-
CD40 engagement on dendritic cells, but not on B or T cells, is required for long-term control of murine gammaherpesvirus 68.J Virol. 2008 Nov;82(22):11016-22. doi: 10.1128/JVI.00919-08. Epub 2008 Sep 3. J Virol. 2008. PMID: 18768977 Free PMC article.
-
Activation of tumor necrosis factor--alpha system in HIV-1 infection: association with markers of immune activation.Infection. 1995 Jan-Feb;23(1):9-15. doi: 10.1007/BF01710050. Infection. 1995. PMID: 7744500
-
Generalized immune activation as a direct result of activated CD4+ T cell killing.J Biol. 2009;8(10):93. doi: 10.1186/jbiol194. J Biol. 2009. PMID: 19943952 Free PMC article.
-
Tuberculosis risk before and after highly active antiretroviral therapy initiation: does HAART increase the short-term TB risk in a low incidence TB setting?J Acquir Immune Defic Syndr. 2011 Aug 1;57(4):305-10. doi: 10.1097/QAI.0b013e3182182e2d. J Acquir Immune Defic Syndr. 2011. PMID: 21423024 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials